Time | Session |
---|---|
2:00pm – 2:10pm | Welcome Address by Express Pharma Speaker : Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare |
2:10pm – 2:25pm | Special Address : Topic : In Pursuit of Excellence Speaker : Ravi Udaya Bhaskar, Director-General, Pharmexcil |
2:25pm – 2:45pm |
Topic : Documented Solutions - How customers benefit from Ideal Cures Speaker : Suresh Pareek, MD, Ideal Cures |
2:45pm – 3:05pm |
Topic : Application of Quality By Design in Development of NovaPure® Closures Speaker : Prabhaharan Sankaran, Technical Account Specialist, West Pharmaceutical Services, India |
3:05pm – 4:05pm | Panel Discussion : Topic : The Pandemic effect on FDD Sub-Topics : - Emerging practices and trends in FDD, post-COVID-19 - Innovations in excipients, ingredients - Optimisation of drug formulation design - Lessons in targeted drug delivery from the pandemic - Role of automation and AI in FDD - Smart drug delivery systems - Accelerating vaccine formulation development Panelists : Dr Alagumurugan Alagarswamy, VP & Head-R&D, Maiva Pharma (Moderator) Dr Rakesh Kumar Bhasin, VP & Head R&D (Formulations), Biocon Pharma Dr Sumedha Nadkar, Site Head & Sr Director, Perrigo India Laboratories Dr Pirthi Pal Singh, VP & Head - R&D, Tirupati Group |
4:05pm – 4:35pm |
Topic : Two high-resolution measuring systems for Research & Development and Quality Control Speaker : Uwe Killeman, Field Marketing Manager - Particle Counting & Characterization - Europe, Beckman Coulter Life Sciences |
4:35pm – 4:55pm |
Topic : Automation and AI for Formulations Development Speaker : Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser - Geneva |
4:55pm – 6:00pm | Panel Discussion : Topic : Optimising FR&D to expedite regulatory compliance Sub-Topics : - Upcoming pharma regulations in different markets (US, EU, emerging markets) - Impact of processing and manufacturing tech advancements on FDD - FDD strategies to meet upcoming regulations - Reformulating existing drugs with fewer side effects Panelists : Vinod Arora, Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI) (Moderator) Dr Sajeev Chandran, Director, Adv. Drug Delivery Research & IVIVC/ Biopharmaceutics , Pharma R&D, Lupin Dr Sukhjeet Singh, Chief Scientific Officer, Sentiss Pharma Dr C Muthulingam, VP-Formulations, Mankind Pharma Ravikumar N, Sr VP, MSN Laboratories |